Unknown PHASE3 INTERVENTIONAL 2-arm NCT03583151

Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger

Injection With Amniotic Fluid Versus Corticosteroid in Patients With Stenosing Tenosynovitis: a Randomized, Blinded Trial

Sponsor: J&M Shuler

Conditions Stenosing Tenosynovitis

Interventions Amniotic fluid injection Steroid injection

Updated 5 times since 2018 Last updated: Jun 28, 2018 Started: May 10, 2018 Primary completion: Dec 31, 2018 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03583151, this PHASE3 trial focuses on Stenosing Tenosynovitis and remains ongoing. Sponsored by J&M Shuler, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Enrolling By Invitation → Unknown Status
Aug 2018 — Jul 2020 [monthly]

Enrolling By Invitation PHASE3

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

J&M Shuler
Vivex Biomedical

Data source: J&M Shuler

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, United States